{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T11:51:00Z","timestamp":1783338660312,"version":"3.54.6"},"reference-count":32,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T00:00:00Z","timestamp":1682035200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Objectives<\/jats:title><jats:p>Obesity measurement indexes have certain screening value for metabolic diseases. To investigate associations between metabolic associated fatty liver disease (MAFLD) and obesity measurement indexes, including traditional indexes (BMI, WC, WHtR) and new indexes (ABSI, BRI, VAI, LAP), and assess their screening ability.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>12,658 subjects aged 18-75 at the Health Center of a Class III Grade A Hospital were included, who were divided into MAFLD and non-MAFLD groups. Spearman\u2019s rank correlation was used to study the correlation between MAFLD and obesity measurement indexes. Receiver operating characteristic (ROC) curves were used to calculate the area under the curve (AUC) to evaluate their screening accuracy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>MAFLD had strong correlation with traditional BMI and new index LAP. ROC analysis showed that BMI had the highest AUC (0.89), followed by LAP (0.87). Stratification by BMI, LAP had the highest AUC (0.90) for MAFLD in population without obesity (BMI&amp;lt; 23kg\/m<jats:sup>2<\/jats:sup>), and its optimal cutoff value was 20.75, with a sensitivity and specificity of 85.9% and 79.0%, respectively.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>We proposed a two-step screening strategy for MAFLD, combining BMI and LAP, and defined a high-risk population for MAFLD as follows: 1) BMI \u2265 23 kg\/m<jats:sup>2<\/jats:sup>; and 2) BMI&amp;lt; 23 kg\/m<jats:sup>2<\/jats:sup> and LAP \u2265 20.75.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2023.1163682","type":"journal-article","created":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T04:33:50Z","timestamp":1682051630000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":18,"title":["Comparison between traditional and new obesity measurement index for screening metabolic associated fatty liver disease"],"prefix":"10.3389","volume":"14","author":[{"given":"Hongyan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yupeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiling","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongmei","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaoqi","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,4,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2019.03.004","article-title":"Global liver disease burdens and research trends: analysis from a chinese perspective","volume":"71","author":"Xiao","year":"2019","journal-title":"J Hepatol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)32511-3","article-title":"Non-alcoholic fatty liver disease","volume":"397","author":"Powell","year":"2021","journal-title":"Lancet"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement","volume":"73","author":"Eslam","year":"2020","journal-title":"J Hepatol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","article-title":"Mafld: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease","volume":"158","author":"Eslam","year":"2020","journal-title":"Gastroenterology"},{"key":"B5","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1007\/s12072-020-10094-2","article-title":"The Asian pacific association for the study of the liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease","volume":"14","author":"Eslam","year":"2020","journal-title":"Hepatol Int"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjms.2018.11.006","article-title":"Body adiposity index and body roundness index in identifying insulin resistance among adults without diabetes","volume":"357","author":"Feng","year":"2019","journal-title":"Am J Med Sci"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.26355\/eurrev_201903_17262","article-title":"Lipid accumulation product and visceral adiposity index: two new indices to predict metabolic syndrome in chronic kidney disease","volume":"23","author":"Biyik","year":"2019","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1080\/00325481.2018.1444901","article-title":"Validity of cardiometabolic index, lipid accumulation product, and body adiposity index in predicting the risk of hypertension in chinese population","volume":"130","author":"Wang","year":"2018","journal-title":"Postgrad Med"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.5603\/KP.a2017.0149","article-title":"New indexes of body fat distribution, visceral adiposity index, body adiposity index, waist-to-height ratio, and metabolic disturbances in the obese","volume":"75","author":"Jablonowska-Lietz","year":"2017","journal-title":"Kardiol Pol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"27","DOI":"10.4103\/jhrs.jhrs_114_21","article-title":"Lipid accumulation product better predicts metabolic status in lean polycystic ovary syndrome than that by visceral adiposity index","volume":"15","author":"Banu","year":"2022","journal-title":"J Hum Reprod Sci"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3967\/bes2021.070","article-title":"The improved lipid accumulation product is an accurate index for predicting metabolic syndrome in the xinjiang population","volume":"34","author":"Ding","year":"2021","journal-title":"BioMed Environ Sci"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1177\/0300060519848854","article-title":"Using a body shape index (absi) and body roundness index (bri) to predict risk of metabolic syndrome in peruvian adults","volume":"48","author":"Stefanescu","year":"2020","journal-title":"J Int Med Res"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-020-01095-4","article-title":"Associations between abdominal obesity indices and diabetic complications: chinese visceral adiposity index and neck circumference","volume":"19","author":"Wan","year":"2020","journal-title":"Cardiovasc Diabetol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s12944-021-01560-3","article-title":"Comparison of obesity-related indices for identifying nonalcoholic fatty liver disease: a population-based cross-sectional study in china","volume":"20","author":"Xie","year":"2021","journal-title":"Lipids Health Dis"},{"key":"B15","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s12944-021-01561-2","article-title":"The usefulness of obesity and lipid-related indices to predict the presence of non-alcoholic fatty liver disease","volume":"20","author":"Sheng","year":"2021","journal-title":"Lipids Health Dis"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31150","article-title":"Epidemiological features of NAFLD from 1999 to 2018 in China","volume":"71","author":"Zhou","year":"2020","journal-title":"Hepatology"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1111\/imj.14709","article-title":"Non-alcoholic fatty liver disease: a review of epidemiology, risk factors, diagnosis and management","volume":"50","author":"Huang","year":"2020","journal-title":"Intern Med J"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-020-10023-3","article-title":"The epidemiology of NAFLD in mainland China with analysis by adjusted gross regional domestic product: a meta-analysis","volume":"14","author":"Wu","year":"2020","journal-title":"Hepatol Int"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0039504","article-title":"A new body shape index predicts mortality hazard independently of body mass index","volume":"7","author":"Krakauer","year":"2012","journal-title":"PloS One"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1136\/jech-2014-205257","article-title":"Body shape index in comparison with other anthropometric measures in prediction of total and cause-specific mortality","volume":"70","author":"Dhana","year":"2016","journal-title":"J Epidemiol Community Health"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnesp.2021.10.001","article-title":"A body shape index could serve to identify individuals with metabolic syndrome and increased arterial stiffness in the middle-aged population","volume":"46","author":"Sugiura","year":"2021","journal-title":"Clin Nutr ESPEN"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.13471\/j.cnki.j.sun.yat-sen.univ(med.sci).2021.0607","article-title":"The ability of two new anthropometric indices to screen metabolic associated fatty liver disease among adults","volume":"42","author":"Yang","year":"2021","journal-title":"J Sun Yat-sen Univ"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.4103\/jhrs.jhrs_12_21","article-title":"Visceral adiposity index and lipid accumulation product as diagnostic markers of metabolic syndrome in south indians with polycystic ovary syndrome","volume":"14","author":"Naghshband","year":"2021","journal-title":"J Hum Reprod Sci"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1089\/met.2020.0098","article-title":"Importance of measured body fat, visceral adiposity index, and lipid accumulation product index in predicting cardiometabolic risk factors","volume":"19","author":"Demirbas","year":"2021","journal-title":"Metab Syndr Relat Disord"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1089\/met.2021.0047","article-title":"Visceral adiposity index, triglyceride\/high-density lipoprotein ratio, and lipid accumulation product index to discriminate metabolic syndrome among adult type 1 diabetes patients","volume":"19","author":"Karatas","year":"2021","journal-title":"Metab Syndr Relat Disord"},{"key":"B26","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/j.numecd.2020.01.013","article-title":"Association between coronary atherosclerosis and visceral adiposity index","volume":"30","author":"Bagyura","year":"2020","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"B27","doi-asserted-by":"publisher","first-page":"9693","DOI":"10.1038\/s41598-019-46187-8","article-title":"Visceral adiposity index (vai), lipid accumulation product (lap), and product of triglycerides and glucose (tyg) to discriminate prediabetes and diabetes","volume":"9","author":"Ahn","year":"2019","journal-title":"Sci Rep"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.2337\/dc09-1825","article-title":"Visceral adiposity index: a reliable indicator of visceral fat function associated with cardiometabolic risk","volume":"33","author":"Amato","year":"2010","journal-title":"Diabetes Care"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v26.i42.6514","article-title":"Nonalcoholic fatty liver disease in lean subjects: prognosis, outcomes and management","volume":"26","author":"Chrysavgis","year":"2020","journal-title":"World J Gastroenterol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1002\/hep.30908","article-title":"Lean nafld: a distinct entity shaped by differential metabolic adaptation","volume":"71","author":"Chen","year":"2020","journal-title":"Hepatology"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnu.2018.08.008","article-title":"Lean non-alcoholic fatty liver disease","volume":"38","author":"Wang","year":"2019","journal-title":"Clin Nutr"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1177\/20420188221145650","article-title":"Screening for MAFLD: who, when and how","volume":"14","author":"Pal","year":"2023","journal-title":"Ther Adv Endocrinol Metab"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1163682\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T04:34:09Z","timestamp":1682051649000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1163682\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,21]]},"references-count":32,"alternative-id":["10.3389\/fendo.2023.1163682"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2023.1163682","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,21]]},"article-number":"1163682"}}